Atox Bio
Organization
Trials
Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury
Phase 3, Terminated, 58 people, Jan 19, 2018
Phase 3, Completed, 290 people, Jun 12, 2015
Sources: clinicaltrials.gov
Organization
Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury
Phase 3, Terminated, 58 people, Jan 19, 2018
Phase 3, Completed, 290 people, Jun 12, 2015
Sources: clinicaltrials.gov